Prevalence, determinants and spectrum of attention-deficit hyperactivity disorder (ADHD) medication of children and adolescents in Germany: results of the German Health Interview and Examination Survey (KiGGS).
about
Latest trends in ADHD drug prescribing patterns in children in the UK: prevalence, incidence and persistenceTwelve-year retrospective analysis of outpatients with Attention-Deficit/Hyperactivity Disorder in ShanghaiImplementation of independent nurse prescribing in UK mental health settings: focus on attention-deficit/hyperactivity disorder.Geographic analysis of the variation in the incidence of ADHD in a country with free access to healthcare: a Danish cohort study.Prescription stimulant use is associated with earlier onset of psychosis.Identifying cross-cultural variations in psychostimulant use for attention deficit hyperactivity disorder using linked data.Reduced pain perception in children and adolescents with ADHD is normalized by methylphenidate.Uses and misuses of treatments for ADHD. The second Birgit Olsson lecture.Treatment compliance or medication adherence in children and adolescents on ADHD medication in clinical practice: results from the COMPLY observational study.Comparative treatment patterns, healthcare resource utilization and costs of atomoxetine and long-acting methylphenidate among children and adolescents with attention-deficit/hyperactivity disorder in GermanyInfant atopic eczema and subsequent attention-deficit/hyperactivity disorder--a prospective birth cohort study.Attention deficit-hyperactivity disorder is associated with reduced blood pressure and serum vitamin D levels: results from the nationwide German Health Interview and Examination Survey for Children and Adolescents (KiGGS).Association between immigrant background and ADHD: a nationwide population-based case-control study.Variation in Presentation, Diagnosis, and Management of Children and Adolescents With ADHD Across European Countries.
P2860
Q28596811-9F1B93C5-9FDC-4375-A2EC-2E34D5B86D91Q33744502-14E59977-6CDB-47F9-A84D-5AFD12C06897Q34567343-E30C1156-3A40-4C41-80B7-62C7A99BE37BQ35986924-BAECA228-77D6-469D-96C7-593C5CE123F5Q36242277-787CB024-391E-40F4-B6CD-719418E9B0A4Q36319106-AD0C440C-E1E6-48FC-A565-733DF6ED7A5CQ37118184-8E1EE7CD-F7EB-43D6-A69E-28E70E34BB0CQ38192711-4A5B84E3-D4DA-4518-8CE3-D613CC921557Q38446727-A4AEEAAA-91EB-4155-8C29-64872C3F7C4BQ39211810-8B137BA9-5882-4ABF-BD5F-EE0464D00536Q39304829-66F7B99A-6344-4741-B14B-721A2CA3E89DQ39752543-0A8024CE-2269-41DF-A935-4068DB984726Q40773898-1F3B8397-851B-4AEE-AC01-11467496252FQ50575573-12E5631D-0126-4CA4-8393-FD5D0FB44C75
P2860
Prevalence, determinants and spectrum of attention-deficit hyperactivity disorder (ADHD) medication of children and adolescents in Germany: results of the German Health Interview and Examination Survey (KiGGS).
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Prevalence, determinants and s ...... nd Examination Survey (KiGGS).
@ast
Prevalence, determinants and s ...... nd Examination Survey (KiGGS).
@en
type
label
Prevalence, determinants and s ...... nd Examination Survey (KiGGS).
@ast
Prevalence, determinants and s ...... nd Examination Survey (KiGGS).
@en
prefLabel
Prevalence, determinants and s ...... nd Examination Survey (KiGGS).
@ast
Prevalence, determinants and s ...... nd Examination Survey (KiGGS).
@en
P2093
P2860
P921
P1433
P1476
Prevalence, determinants and s ...... nd Examination Survey (KiGGS).
@en
P2093
Heike Hölling
Michael Huss
Robert Schlack
P2860
P356
10.1136/BMJOPEN-2011-000477
P577
2012-11-23T00:00:00Z